|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
10,820,000 |
Market
Cap: |
1.30(B) |
Last
Volume: |
401,241 |
Avg
Vol: |
400,142 |
52
Week Range: |
$115.55 - $119.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Heska sells veterinary and animal health diagnostic and specialty products. Co.'s primary focus is on the canine and feline healthcare space. Co.'s business is composed of two segments: North America and International. Co.'s main product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
14,458 |
Total Buy Value |
$0 |
$0 |
$0 |
$851,078 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2014-11-21 |
4 |
S |
$15.45 |
$146,788 |
D/D |
(9,499) |
15,775 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2014-11-21 |
4 |
OE |
$8.80 |
$83,591 |
D/D |
9,499 |
25,039 |
|
- |
|
Grieve Robert B |
Executive Chair |
|
2014-11-21 |
4 |
S |
$15.54 |
$15,540 |
D/D |
(1,000) |
122,815 |
|
- |
|
Grieve Robert B |
Executive Chair |
|
2014-11-20 |
4 |
S |
$15.25 |
$38,225 |
D/D |
(2,500) |
123,815 |
|
- |
|
Grieve Robert B |
Executive Chair |
|
2014-11-19 |
4 |
S |
$15.10 |
$45,350 |
D/D |
(3,000) |
126,315 |
|
- |
|
Aylesworth William A |
Director |
|
2014-11-03 |
4 |
S |
$13.67 |
$68,355 |
D/D |
(5,000) |
37,397 |
|
- |
|
Aylesworth William A |
Director |
|
2014-11-03 |
4 |
OE |
$8.60 |
$43,000 |
D/D |
5,000 |
42,397 |
|
- |
|
Grieve Robert B |
Chief Executive Officer |
|
2014-08-25 |
4 |
S |
$13.40 |
$13,400 |
D/D |
(1,000) |
129,315 |
|
- |
|
Aylesworth William A |
Director |
|
2014-08-18 |
4 |
S |
$13.47 |
$21,654 |
D/D |
(1,600) |
37,397 |
|
- |
|
Aylesworth William A |
Director |
|
2014-08-12 |
4 |
OE |
$4.60 |
$23,000 |
D/D |
5,000 |
38,997 |
|
- |
|
Grieve Robert B |
Executive Chair and Director |
|
2014-08-04 |
4 |
S |
$13.21 |
$162,833 |
D/D |
(12,000) |
130,315 |
|
- |
|
Aylesworth William A |
Director |
|
2014-07-07 |
4 |
OE |
$8.00 |
$33,600 |
D/D |
4,200 |
33,997 |
|
- |
|
Grieve Robert B |
Executive Chair and Director |
|
2014-06-05 |
4 |
S |
$10.65 |
$10,010 |
D/D |
(936) |
142,315 |
|
- |
|
Aylesworth William A |
Director |
|
2014-05-14 |
4 |
S |
$10.80 |
$45,717 |
D/D |
(4,200) |
29,797 |
|
- |
|
Wilson Kevin S. |
President and COO |
|
2014-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
130,000 |
261,810 |
|
- |
|
Riley Sharon L. |
Director |
|
2014-03-31 |
4 |
B |
$10.81 |
$32,430 |
D/D |
3,000 |
4,000 |
2.39 |
- |
|
Wrenn Carol |
Director |
|
2014-03-31 |
4 |
B |
$10.50 |
$10,500 |
D/D |
1,000 |
4,000 |
2.39 |
- |
|
Grieve Robert B |
Chief Executive Officer |
|
2014-03-31 |
4 |
S |
$10.50 |
$73,520 |
D/D |
(7,000) |
143 |
|
- |
|
Grieve Robert B |
Chief Executive Officer |
|
2014-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
63,572 |
150,251 |
|
- |
|
Wilson Kevin S. |
President and COO |
|
2014-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
110,000 |
131,810 |
|
- |
|
Gordon G Irwin |
Director |
|
2013-03-29 |
4 |
D |
$9.30 |
$986 |
D/D |
(106) |
9,504 |
|
- |
|
Gordon G Irwin |
Director |
|
2013-03-29 |
4 |
OE |
$8.80 |
$994 |
D/D |
113 |
9,610 |
|
- |
|
Gordon G Irwin |
Director |
|
2013-03-15 |
4 |
D |
$8.99 |
$494 |
D/D |
(55) |
9,497 |
|
- |
|
Gordon G Irwin |
Director |
|
2013-03-15 |
4 |
OE |
$7.80 |
$499 |
D/D |
64 |
9,552 |
|
- |
|
Aylesworth William A |
Director |
|
2013-03-01 |
4 |
B |
$8.32 |
$16,679 |
D/D |
2,000 |
33,997 |
2.39 |
- |
|
678 Records found
|
|
Page 19 of 28 |
|
|